Nanexa and Novo Nordisk have reached a global licensing and cooperation agreement worth €1,165 billion for long-acting injections.

Zhitongcaijing · 2d ago
Nanexa and Novo Nordisk have reached a global licensing and cooperation agreement worth €1,165 billion for long-acting injections.